Weir, Ashley
Kang, Eun-Young
Meagher, Nicola S. http://orcid.org/0000-0001-9134-2118
Nelson, Gregg S.
Ghatage, Prafull http://orcid.org/0000-0002-2371-0844
Lee, Cheng-Han
Riggan, Marjorie J. http://orcid.org/0000-0002-3701-8031
Gentry-Maharaj, Aleksandra
Ryan, Andy
Singh, Naveena
Widschwendter, Martin http://orcid.org/0000-0002-7778-8380
Alsop, Jennifer
Anglesio, Michael S.
Beckmann, Matthias W.
Berger, Jessica
Bisinotto, Christiani
Boros, Jessica
Brand, Alison H.
Brenton, James D. http://orcid.org/0000-0002-5738-6683
Brooks-Wilson, Angela
Carney, Michael E.
Cunningham, Julie M. http://orcid.org/0000-0002-8159-3025
Cushing-Haugen, Kara L.
Cybulski, Cezary
Elishaev, Esther
Erber, Ramona
Fereday, Sian
Fischer, Anna
Paz-Ares, Luis
Gayarre, Javier
Gilks, Blake C.
Grube, Marcel
Harnett, Paul R.
Harris, Holly R.
Hartmann, Arndt
Hein, Alexander http://orcid.org/0000-0003-2601-3398
Hendley, Joy
Hernandez, Brenda Y.
Heublein, Sabine
Huang, Yajue
Huzarski, Tomasz
Jakubowska, Anna http://orcid.org/0000-0002-5650-0501
Jimenez-Linan, Mercedes
Kennedy, Catherine J. http://orcid.org/0000-0002-4465-5784
Kommoss, Felix K. F. http://orcid.org/0000-0003-0876-9087
Koziak, Jennifer M.
Kraemer, Bernhard
Le, Nhu D.
Lesnock, Jaime
Lester, Jenny
Lubiński, Jan
Menkiszak, Janusz
Ney, Britta
Olawaiye, Alexander
Orsulic, Sandra
Osorio, Ana http://orcid.org/0000-0001-8124-3984
Robles-Díaz, Luis
Ruebner, Matthias
Shah, Mitul
Sharma, Raghwa
Shvetsov, Yurii B.
Steed, Helen
Talhouk, Aline
Taylor, Sarah E.
Traficante, Nadia
Vierkant, Robert A. http://orcid.org/0000-0001-6242-5221
Wang, Chen
Wilkens, Lynne R.
Winham, Stacey J. http://orcid.org/0000-0002-8492-9102
Benitez, Javier
Berchuck, Andrew
Bowtell, David D. http://orcid.org/0000-0001-9089-7525
Candido dos Reis, Francisco J. http://orcid.org/0000-0001-5758-5917
Cook, Linda S.
DeFazio, Anna http://orcid.org/0000-0003-0057-4744
Bowtell, D.
DeFazio, A.
Traficante, N.
Fereday, S.
Brand, A.
Harnett, P.
Sharma, R.
Doherty, Jennifer A. http://orcid.org/0000-0002-1454-8187
Fasching, Peter A. http://orcid.org/0000-0003-4885-8471
García, María J. http://orcid.org/0000-0002-2236-9912
Goode, Ellen L.
Goodman, Marc T.
Gronwald, Jacek
Huntsman, David G.
Karlan, Beth Y. http://orcid.org/0000-0002-9451-2933
Kommoss, Stefan
Modugno, Francesmary
Schildkraut, Joellen M.
Sinn, Hans-Peter http://orcid.org/0000-0003-2836-6699
Staebler, Annette
Kelemen, Linda E.
Ford, Caroline E. http://orcid.org/0000-0002-4438-2309
Menon, Usha http://orcid.org/0000-0003-3708-1732
Pharoah, Paul D. P. http://orcid.org/0000-0001-8494-732X
Köbel, Martin
Ramus, Susan J. http://orcid.org/0000-0003-0005-7798
,
Article History
Received: 25 January 2022
Revised: 1 September 2022
Accepted: 4 October 2022
First Online: 2 November 2022
Competing interests
: ADF, SF, and NT have received a research grant from AstraZeneca, not directly related to this work. DDB receives funding from Astra Zeneca and Genentech Roche for the conduct of research studies and clinical trials unrelated to the work described in this article. DGH is a founder and Chief Medical Officer of Contextual Genomics, a somatic mutation testing laboratory; the company’s work and interests do not overlap with the subject of and methodologies used in this article. UM had stock ownership in Abcodia until October 2021, and UCL had a license agreement (2011–2021) with Abcodia not related to this work. PDPP is a member of the <i>British Journal Cancer</i> Editorial Board. MW is a shareholder of Sola Diagnostics GmbH and BreOva Health Ltd. GSN received speaker/advisory fees from 3M, GSK, Medtronic, and Abbott outside of the submitted work. AH has received honoraria from BMS, MSD, Roche, AstraZeneca, Boehringer Ingelheim, Abbvie, Jansen-Cilag, and Ipsen. RE has received honoraria from Roche, Eisai, Pfizer, and Novartis and travel grants from BioNTech. The institution of AH and RE conducts research for AstraZeneca, Roche, Janssen-Cilag, NanoString Technologies, Novartis, Cepheid, and BioNTech. All other authors declare no competing interests.
: The majority of the participants provided informed consent. Three of the 21 sites had a waiver of consent, listed in Supplementary Table InternalRef removed. The study was approved by the University of New South Wales, Sydney, Human Research Ethics Application (HREA) Panel D: Biomedical, HC16299. The ethics committees that approved the individual participating sites are listed in Supplementary Table InternalRef removed. The study was performed in accordance with the Declaration of Helsinki.